{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-[(Z)-3-hydroxyprop-1-enyl]-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
| image = Lilopristone skeletal.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 97747-88-1
| CAS_supplemental = 
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 13490845
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 11644476
| UNII = 3GL26H7N6T
| KEGG = 
| ChEBI = 
| ChEMBL = 1908329

<!--Chemical data-->
| C=29 | H=37 | N=1 | O=3
| molecular_weight = 447.619 g/mol
| SMILES = C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(/C=C\CO)O)C5=CC=C(C=C5)N(C)C
| StdInChI_Ref = 
| StdInChI = 1S/C29H37NO3/c1-28-18-25(19-5-8-21(9-6-19)30(2)3)27-23-12-10-22(32)17-20(23)7-11-24(27)26(28)13-15-29(28,33)14-4-16-31/h4-6,8-9,14,17,24-26,31,33H,7,10-13,15-16,18H2,1-3H3/b14-4-/t24-,25+,26-,28-,29-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = RCOWGILQXUPXEW-FUSOFXSQSA-N
| synonyms = ZK-98734; ZK-734; 11β-(4-(Dimethylamino)phenyl)-17β-hydroxy-17α-((Z)-3-hydroxypropenyl)estra-4,9-dien-3-one
}}

'''Lilopristone''' ([[International Nonproprietary Name|INN]]) (developmental code names '''ZK-98734''', '''ZK-734''') is a [[synthetic compound|synthetic]], [[steroid]]al [[antiprogestogen]] with additional [[antiglucocorticoid]] activity which was developed by [[Schering AG|Schering]] and was patented in 1985.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA733|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=733–}}</ref><ref name="Rao2009">{{cite book|author=Rao|title=Textbook of Gynaecology|url=https://books.google.com/books?id=OzOq3Ddfg-8C&pg=PA187|date=November 2009|publisher=Elsevier India|isbn=978-81-312-1526-5|pages=187–}}</ref><ref name="BairdSchütz2013">{{cite book|author1=D.T. Baird|author2=Günther Schütz|author3=R. Krattenmacher|title=Organ-Selective Actions of Steroid Hormones|url=https://books.google.com/books?id=sOUkBAAAQBAJ&pg=PA108|date=9 March 2013|publisher=Springer Science & Business Media|isbn=978-3-662-09153-1|pages=108–}}</ref> It is described as an [[abortifacient]] and [[endometrium|endometrial]] [[hormonal contraception|contraceptive]].<ref name="Elks2014" /><ref name="Deshpande2016">{{cite book|author=Hemant Deshpande|title=Practical Management of Ovulation Induction|url=https://books.google.com/books?id=GMMqCwAAQBAJ&pg=PA29|date=12 February 2016|publisher=JP Medical Ltd|isbn=978-93-5250-028-4|pages=29–}}</ref> The drug differs from [[mifepristone]] only in the structure of its C17α [[side chain]], and is said to have much reduced [[antiglucocorticoid]] activity in comparison.<ref name="LookPérez-Palacios1994">{{cite book|author1=P. F. A. Van Look|author2=Gregorio Pérez-Palacios|author3=World Health Organization|title=Contraceptive research and development, 1984 to 1994: the road from Mexico City to Cairo and beyond|url=https://books.google.com/books?id=vg3bAAAAMAAJ|year=1994|publisher=Oxford University Press|isbn=978-0-19-563630-7|page=169|quote=[...] lilopristone, which differs from mifepristone only in the structure of the 17a side chain, is said to have a much reduced antiglucocorticoid activity (Neef et al., 1984).}}</ref>

==See also==
* [[Aglepristone]]
* [[Onapristone]]
* [[Telapristone]]
* [[Toripristone]]

==References==
{{Reflist|2}}


{{Glucocorticoid receptor modulators}}
{{Progesterone receptor modulators}}

[[Category:Abortifacients]]
[[Category:Alcohols]]
[[Category:Amines]]
[[Category:Antiglucocorticoids]]
[[Category:Antiprogestogens]]
[[Category:Estranes]]
[[Category:Ketones]]


{{steroid-stub}}
{{genito-urinary-drug-stub}}